Publications by authors named "E E Bancroft"
Background: The presence of germline mutations plays an increasingly important role in risk assessment and treatment of prostate cancer (PrCa). Screening for high-risk mutations in subsets of patients is becoming routine. We explore the prevalence of germline genetic mutations in men with metastatic castration-resistant prostate cancer (mCRPC) recruited to the BARCODE2 trial.
View Article and Find Full Text PDFBackground: Infection prevention and control (IPC) programs are essential to prevent and control the spread of multidrug-resistant organisms in healthcare facilities (HCFs). The current implementation of these programs in Latin America remains largely unknown.
Methods: We conducted a mixed-methods evaluation of IPC program implementation in HCFs from Guatemala, Panama, Ecuador, and Argentina, March-July 2022.
Objectives: This study aimed to conduct an epidemiological and genomic investigation of a hospital outbreak of , and implement measures for its control.
Methods: We collected demographic and clinical data from medical records of patients with from January 2017 to June 2019 after identifying increased cases in April 2019. Point-prevalence surveys for colonisation were conducted in the critical care units (CCU).
Article Synopsis
- Limited information exists on healthcare workers' views about infection prevention and control (IPC) in Latin America, prompting a survey conducted across 30 hospitals in the region.
- The survey, completed by 1,340 healthcare workers, revealed high self-reported compliance with hand hygiene and prevention measures, but a notable gap in perceived peer compliance.
- Findings highlighted the need for enhanced training and awareness among healthcare workers, particularly physicians, regarding IPC practices and healthcare-associated infection (HAI) rates.
Background: Lynch syndrome carriers ('carriers') are presented with complex, emotionally laden choices regarding management of increased genetic cancer risks. Decision aids encourage active involvement in values-based health decisions. This paper aimed to address the research question: How do Lynch syndrome carriers make sense of their chances of developing cancer, and what are the implications for providing support with decision making about genetic cancer risk management?
Methods: Adult carriers were recruited through a genetics service or involvement with Lynch Syndrome UK.